Molecular signatures of antibody responses derived from a systems biology study of five human vaccines.
Many vaccines induce protective immunity via antibodies. Systems biology approaches have been used to determine signatures that can be used to predict vaccine-induced immunity in humans, but whether there is a 'universal signature' that can be used to predict antibody responses to any vaccine is unknown. Here we did systems analyses of immune responses to the polysaccharide and conjugate vaccines against meningococcus in healthy adults, in the broader context of published studies of vaccines against yellow fever virus and influenza virus. To achieve this, we did a large-scale network integration of publicly available human blood transcriptomes and systems-scale databases in specific biological contexts and deduced a set of transcription modules in blood. Those modules revealed distinct transcriptional signatures of antibody responses to different classes of vaccines, which provided key insights into primary viral, protein recall and anti-polysaccharide responses. Our results elucidate the early transcriptional programs that orchestrate vaccine immunity in humans and demonstrate the power of integrative network modeling.
Authors
Shuzhao Li; Nadine Rouphael; Sai Duraisingham; Sandra Romero-Steiner; Scott Presnell; Carl Davis; Daniel S Schmidt; Scott E Johnson; Andrea Milton; Gowrisankar Rajam; Sudhir Kasturi; George M Carlone; Charlie Quinn; Damien Chaussabel; A Karolina Palucka; Mark J Mulligan; Rafi Ahmed; David S Stephens; Helder I Nakaya; Bali Pulendran
External link
Publication Year
Publication Journal
Associeted Project
Systems Vaccinology
Lista de serviços
-
Is the gut microbiome key to modulating vaccine efficacy?Is the gut microbiome key to modulating vaccine efficacy?
-
Toxicogenomic and bioinformatics platforms to identify key molecular mechanisms of a curcumin-analogue DM-1 toxicity in melanoma cells.Toxicogenomic and bioinformatics platforms to identify key molecular mechanisms of a curcumin-analogue DM-1 toxicity in melanoma cells.